ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $156,000 | -5.5% | 253,918 | +100.0% | 0.00% | – |
| Q3 2018 | $165,000 | -4.1% | 126,959 | -0.5% | 0.00% | – |
| Q2 2018 | $172,000 | -38.8% | 127,543 | -34.4% | 0.00% | – |
| Q1 2018 | $281,000 | -35.6% | 194,375 | +0.3% | 0.00% | – |
| Q4 2017 | $436,000 | -29.3% | 193,875 | +6.7% | 0.00% | – |
| Q3 2017 | $617,000 | +0.3% | 181,682 | +4.8% | 0.00% | – |
| Q2 2017 | $615,000 | +8.8% | 173,404 | +4.3% | 0.00% | – |
| Q1 2017 | $565,000 | -24.0% | 166,210 | +2.9% | 0.00% | – |
| Q4 2016 | $743,000 | +19.1% | 161,526 | +9.6% | 0.00% | – |
| Q3 2016 | $624,000 | +193.0% | 147,387 | +65.5% | 0.00% | – |
| Q2 2016 | $213,000 | -40.0% | 89,034 | +17.8% | 0.00% | – |
| Q1 2016 | $355,000 | +19.5% | 75,575 | 0.0% | 0.00% | – |
| Q4 2015 | $297,000 | +3.1% | 75,575 | +1.5% | 0.00% | – |
| Q3 2015 | $288,000 | – | 74,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |